Kidney stones market size to grow by USD 566.78 million between 2022 and 2027; Growth driven by rising incidence of urolithiasis - Technavio

NEW YORK, March 29, 2023 /PRNewswire/ -- The kidney stones market size is estimated to increase by USD 566.78 million from 2022 to 2027, at a CAGR of 5.42%, according to a recent market study by Technavio. The growth of the market is driven by the rising incidence of urolithiasis. The incidence of urolithiasis is increasing among individuals due to changes in lifestyles and food intake. It is one of the most common urologic diseases worldwide. The prevalence of the condition ranges from 1% to 13% in different regions across the globe. Ureteroscopic laser lithotripsy is widely used in the treatment of urolithiasis. Similarly, ureteroscopy (URS) is gaining popularity among patients, as it reduces the procedure time and the number of sittings and eliminates the use of stone-retrieving baskets. This treatment is advised for patients with pregnancy, morbid obesity, and blood clotting disorders. Thus, the rising prevalence of urolithiasis is expected to have a positive impact on the growth of the global kidney stones market during the forecast period. Discover some insights on market size before buying the full report - Request a sample report

Segmentation Analysis

• The market is segmented by type (ureteroscopy, lithotripsy, and percutaneous nephrolithotomy (PCNL)), end-user (hospitals, specialty clinics, and ambulatory surgical centers), and geography (North America, Europe, Asia, and Rest of World (ROW)).
• The market growth in the ureteroscopy segment will be significant during the forecast period. Ureteroscopy (URS) is gaining popularity due to its high success rate compared with lithotripsy. In addition, technological advances such as the miniaturization of ureteroscopic baskets and instruments and the development of single-use digital ureteroscopes are driving the growth of the segment.
• North America will account for 43% of the market growth during the forecast period. The growth of the regional market can be attributed to various factors, including the high demand for superior medical technologies and the increased adoption of minimally invasive treatment options such as URS. Also, the presence of advanced healthcare infrastructure and the strong market presence of the leading vendors are driving the growth of the kidney stones market in North America.

Chart & data table on 5-year historic (2017-2021) market size, comparative analysis of segments, and Y-O-Y growth of kidney stones market - Download Sample Report

Vendor Analysis

The global kidney stones market is fragmented due to the presence of many established vendors that have a sizeable market presence. The competition in the market is more intense with the increase in the demand for kidney stone therapeutics from regions such as MEA, North America, and Europe. Vendors are investing in the development of customized solutions to increase their foothold in the market. Healthcare facilities select vendors based on the degree of superiority and features of their kidney stone therapeutics. This enables vendors to compete with larger players more effectively, which has intensified competition in the market. Also, vendors need to continuously innovate their offerings and build capabilities as there is less service differentiation.

The market report offers information on the criticality of inputs, R&D, CAPEX, technology, and products of key vendors, including:

• Aristo Pharma GmbH - The company offers kidney stone therapeutic, namely Flodart.
• Bausch Health Co Inc. - The company offers kidney stone therapeutic, namely CUPRIMINE.
• Biomedix Siomond Pharma - The company offers kidney stone therapeutic, namely KERENDIA.
• Cmg Biotech Pvt. Ltd. - The company offers kidney stone therapeutic, namely STON1 B6 Solution.

Why Buy?

• Add credibility to strategy
• Analyzes competitor's offerings
• Get a holistic view of the market

Grow your profit margin with Technavio - Buy the Report

What are the key data covered in this kidney stones market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the kidney stones market between 2023 and 2027
• Precise estimation of the size of the kidney stones market and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the kidney stones market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of kidney stones market vendors

Gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform

Related Reports:

• The kidney stones management devices market size is expected to increase by USD 295.35 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.8%. The market is segmented by method (URS, ESWL, and PCNL) and geography (North America, Europe, Asia, and Rest of World (ROW)).
• The polycystic kidney disease drugs market size is expected to increase by USD 510.69 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 6.7%. The market is segmented by type (ADPKD and ARPKD) and geography (North America, Europe, Asia, and Rest of World (ROW)).

Browse through Technavio's Health Care Market Reports

Table of contents:

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary ? Chart on Market Overview
• Exhibit 02: Executive Summary ? Data Table on Market Overview
• Exhibit 03: Executive Summary ? Chart on Global Market Characteristics
• Exhibit 04: Executive Summary ? Chart on Market by Geography
• Exhibit 05: Executive Summary ? Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary ? Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary ? Chart on Incremental Growth
• Exhibit 08: Executive Summary ? Data Table on Incremental Growth
• Exhibit 09: Executive Summary ? Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global kidney stones market 2017 - 2021
• Exhibit 18: Historic Market Size ? Data Table on Global kidney stones market 2017 - 2021 ($ million)

• 4.2 Type Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size ? Type Segment 2017 - 2021 ($ million)

• 4.3 End-user Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size ? End-user Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size ? Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size ? Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary 
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers ? Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers ? Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants ? Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes ? Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry 
• Exhibit 28: Threat of rivalry ? Impact of key factors in 2022 and 2027

• 5.7 Market condition 
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

• 6.1 Market segments 
• Exhibit 30: Chart on Type - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Type - Market share 2022-2027 (%)

• 6.2 Comparison by Type 
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type

• 6.3 Ureteroscopy - Market size and forecast 2022-2027
• Exhibit 34: Chart on Ureteroscopy - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Ureteroscopy - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Ureteroscopy - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Ureteroscopy - Year-over-year growth 2022-2027 (%)

• 6.4 Lithotripsy - Market size and forecast 2022-2027
• Exhibit 38: Chart on Lithotripsy - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Lithotripsy - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Lithotripsy - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Lithotripsy - Year-over-year growth 2022-2027 (%)

• 6.5 Percutaneous nephrolithotomy (PCNL) - Market size and forecast 2022-2027 
• Exhibit 42: Chart on Percutaneous nephrolithotomy (PCNL) - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Percutaneous nephrolithotomy (PCNL) - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Percutaneous nephrolithotomy (PCNL) - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Percutaneous nephrolithotomy (PCNL) - Year-over-year growth 2022-2027 (%)

• 6.6 Market opportunity by Type 
• Exhibit 46: Market opportunity by Type ($ million)
• Exhibit 47: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments 
• Exhibit 48: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 49: Data Table on End-user - Market share 2022-2027 (%)

• 7.2 Comparison by End-user 
• Exhibit 50: Chart on Comparison by End-user
• Exhibit 51: Data Table on Comparison by End-user

• 7.3 Hospitals - Market size and forecast 2022-2027
• Exhibit 52: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)

• 7.4 Specialty clinics - Market size and forecast 2022-2027
• Exhibit 56: Chart on Specialty clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Specialty clinics - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Specialty clinics - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Specialty clinics - Year-over-year growth 2022-2027 (%)

• 7.5 Ambulatory surgical centers - Market size and forecast 2022-2027 
• Exhibit 60: Chart on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)

• 7.6 Market opportunity by End-user 
• Exhibit 64: Market opportunity by End-user ($ million)
• Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 67: Chart on Market share by geography 2022-2027 (%)
• Exhibit 68: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027
• Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 China - Market size and forecast 2022-2027
• Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.10 Canada - Market size and forecast 2022-2027
• Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)

• 9.11 UK - Market size and forecast 2022-2027
• Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 107: Market opportunity by geography ($ million)
• Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 109: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape 
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption 
• Exhibit 111: Overview on factors of disruption

• 11.4 Industry risks 
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered 
• Exhibit 113: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 114: Matrix on vendor position and classification

• 12.3 Anvik Biotech 
• Exhibit 115: Anvik Biotech - Overview
• Exhibit 116: Anvik Biotech - Product / Service
• Exhibit 117: Anvik Biotech - Key offerings

• 12.4 Aristo Pharma GmbH 
• Exhibit 118: Aristo Pharma GmbH - Overview
• Exhibit 119: Aristo Pharma GmbH - Product / Service
• Exhibit 120: Aristo Pharma GmbH - Key offerings

• 12.5 Bausch Health Co Inc. 
• Exhibit 121: Bausch Health Co Inc. - Overview
• Exhibit 122: Bausch Health Co Inc. - Business segments
• Exhibit 123: Bausch Health Co Inc. - Key news
• Exhibit 124: Bausch Health Co Inc. - Key offerings
• Exhibit 125: Bausch Health Co Inc. - Segment focus

• 12.6 Bayer AG 
• Exhibit 126: Bayer AG - Overview
• Exhibit 127: Bayer AG - Business segments
• Exhibit 128: Bayer AG - Key news
• Exhibit 129: Bayer AG - Key offerings
• Exhibit 130: Bayer AG - Segment focus

• 12.7 Cipla Ltd. 
• Exhibit 131: Cipla Ltd. - Overview
• Exhibit 132: Cipla Ltd. - Business segments
• Exhibit 133: Cipla Ltd. - Key news
• Exhibit 134: Cipla Ltd. - Key offerings
• Exhibit 135: Cipla Ltd. - Segment focus

• 12.8 Dr Reddys Laboratories Ltd. 
• Exhibit 136: Dr Reddys Laboratories Ltd. - Overview
• Exhibit 137: Dr Reddys Laboratories Ltd. - Business segments
• Exhibit 138: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibit 139: Dr Reddys Laboratories Ltd. - Segment focus

• 12.9 Emcure Pharmaceuticals Ltd. 
• Exhibit 140: Emcure Pharmaceuticals Ltd. - Overview
• Exhibit 141: Emcure Pharmaceuticals Ltd. - Product / Service
• Exhibit 142: Emcure Pharmaceuticals Ltd. - Key offerings

• 12.10 GlaxoSmithKline Plc 
• Exhibit 143: GlaxoSmithKline Plc - Overview
• Exhibit 144: GlaxoSmithKline Plc - Business segments
• Exhibit 145: GlaxoSmithKline Plc - Key offerings
• Exhibit 146: GlaxoSmithKline Plc - Segment focus

• 12.11 Intas Pharmaceuticals Ltd. 
• Exhibit 147: Intas Pharmaceuticals Ltd. - Overview
• Exhibit 148: Intas Pharmaceuticals Ltd. - Product / Service
• Exhibit 149: Intas Pharmaceuticals Ltd. - Key offerings

• 12.12 Macleods Pharmaceuticals Ltd. 
• Exhibit 150: Macleods Pharmaceuticals Ltd. - Overview
• Exhibit 151: Macleods Pharmaceuticals Ltd. - Product / Service
• Exhibit 152: Macleods Pharmaceuticals Ltd. - Key offerings

• 12.13 Medinova Diagnostic Services Ltd. 
• Exhibit 153: Medinova Diagnostic Services Ltd. - Overview
• Exhibit 154: Medinova Diagnostic Services Ltd. - Product / Service
• Exhibit 155: Medinova Diagnostic Services Ltd. - Key offerings

• 12.14 Pfizer Inc. 
• Exhibit 156: Pfizer Inc. - Overview
• Exhibit 157: Pfizer Inc. - Product / Service
• Exhibit 158: Pfizer Inc. - Key news
• Exhibit 159: Pfizer Inc. - Key offerings

• 12.15 Walter Bushnell 
• Exhibit 160: Walter Bushnell - Overview
• Exhibit 161: Walter Bushnell - Product / Service
• Exhibit 162: Walter Bushnell - Key offerings

• 12.16 Windlas Biotech Pvt. Ltd. 
• Exhibit 163: Windlas Biotech Pvt. Ltd. - Overview
• Exhibit 164: Windlas Biotech Pvt. Ltd. - Product / Service
• Exhibit 165: Windlas Biotech Pvt. Ltd. - Key offerings

• 12.17 Worth Medicines Pvt. Ltd. 
• Exhibit 166: Worth Medicines Pvt. Ltd. - Overview
• Exhibit 167: Worth Medicines Pvt. Ltd. - Product / Service
• Exhibit 168: Worth Medicines Pvt. Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 169: Inclusions checklist
• Exhibit 170: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 171: Currency conversion rates for US$

• 13.4 Research methodology 
• Exhibit 172: Research methodology
• Exhibit 173: Validation techniques employed for market sizing
• Exhibit 174: Information sources

• 13.5 List of abbreviations 
• Exhibit 175: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

SOURCE Technavio